D. V. Parke
- Pharmacology top 0.05%
- Molecular Biology top 10%
- Cancer Research top 2%
- Oncology top 5%
- Organic Chemistry top 5%
- Co-authors
- Costas IoannidesD. F. V. LewisDavid F. LewisDiana AndersonA Yardley-JonesA. M. SymonsLaurence J. KingAndrzej Sapota
- Topics
- Pharmacogenetics and Drug Metabolism (63 papers)Carcinogens and Genotoxicity Assessment (26 papers)Drug Transport and Resistance Mechanisms (22 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
D. V. Parke
148 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Pharmacology 1.6k
- Molecular Biology 1.1k
- Cancer Research 656
- Oncology 620
- Organic Chemistry 555
Countries citing papers authored by D. V. Parke
This map shows the geographic impact of D. V. Parke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. V. Parke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. V. Parke more than expected).
Fields of papers citing papers by D. V. Parke
This network shows the impact of papers produced by D. V. Parke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. V. Parke. The network helps show where D. V. Parke may publish in the future.
Co-authorship network of co-authors of D. V. Parke
This figure shows the co-authorship network connecting the top 25 collaborators of D. V. Parke. A scholar is included among the top collaborators of D. V. Parke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. V. Parke. D. V. Parke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 19 | |
| 2 | 21 | |
| 3 | 31 | |
| 4 | 19 | |
| 5 | 17 | |
| 6 | 29 | |
| 7 | 65 | |
| 8 | 7 | |
| 9 | 2 | |
| 10 | 51 | |
| 11 | 203 | |
| 12 | 11 | |
| 13 | 12 | |
| 14 | 1 | |
| 15 | 3 | |
| 16 | 2 | |
| 17 | 38 | |
| 18 | 111 | |
| 19 | 4 | |
| 20 | 22 |
About D. V. Parke
D. V. Parke is a scholar working on Pharmacology, Biochemistry and Cancer Research, having authored 148 papers that have together received 4.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (63 papers), Carcinogens and Genotoxicity Assessment (26 papers) and Drug Transport and Resistance Mechanisms (22 papers). The work is most often cited by research in Pharmacology (1.6k citations), Cancer Research (656 citations) and Biochemistry (296 citations). D. V. Parke has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Costas Ioannides, D. F. V. Lewis, David F. Lewis, Diana Anderson, A Yardley-Jones, A. M. Symons, Laurence J. King, Andrzej Sapota, M. Delaforge and R. T. Williams. Their work appears in journals such as Nature, Biochemical Journal and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.